References
- Bachelet T, Couzi L, Lepreux S, et al. 2013. Kidney intragraft donor-specific antibodies as determinant of antibody-mediated lesions and poor graft outcome. Am J Transplant, 13, 2855–2864.
- Ebrahimi A, Rahim F. 2014. Recent immunomodulatory strategies in transplantation. Immunol Invest, 43, 829–837.
- Fujiwara K, Shimano K, Tanaka H, et al. 2009. Application of bead array technology to simultaneous detection of human leucocyte antigen and human platelet antigen antibodies. Vox Sang, 96, 244–251.
- Hubscher SG. 2012. Antibody-mediated rejection in the liver allograft. Curr Opin Organ Transplant, 17, 280–286.
- Laftavi MR, Pankewycz O, Feng L, et al. 2015. Combined induction therapy with rabbit antithymocyte globulin and rituximab in highly sensitized renal recipients. Immunol Invest, 44, 373–384.
- Lee H, Min JW, Kim JI, et al. 2016. Clinical significance of HLA-DQ antibodies in the development of chronic antibody-mediated rejection and allograft failure in kidney transplant recipients. Medicine (Baltimore), 95, e3094.
- Lesage J, Noel R, Lapointe I, et al. 2015. Donor-specific antibodies, C4d and their relationship with the prognosis of transplant glomerulopathy. Transplantation, 99, 69–76.
- Loupy A, Hill GS, Suberbielle C, et al. 2011. Significance of C4d Banff scores in early protocol biopsies of kidney transplant recipients with preformed donor-specific antibodies (DSA). Am J Transplant, 11, 56–65.
- Muczynski KA, Cotner T, Anderson SK. 2001. Unusual expression of human lymphocyte antigen class II in normal renal microvascular endothelium. Kidney Int, 59, 488–497.
- Neau-Cransac M, Le Bail B, Guidicelli G, et al. 2015. Evolution of serum and intra-graft donor-specific anti-HLA antibodies in a patient with two consecutive liver transplantations. Transpl Immunol, 33, 58–62.
- Nishimura K, Hashimoto M, Kinoshita T, et al. 2014. Excellent results of immunocomplex capture fluorescence analysis-I for cross-match test in renal transplantation. Transplant Proc, 46, 332–335.
- Pankewycz O, Soliman K, Laftavi MR. 2014. The increasing clinical importance of alloantibodies in kidney transplantation. Immunol Invest, 43, 775–789.
- Redfield RR, Ellis TM, Zhong W, et al. 2016. Current outcomes of chronic active antibody mediated rejection – A large single center retrospective review using the updated BANFF 2013 criteria. Hum Immunol.
- Rubel C, Miliani de Marval P, Vermeulen M, et al. 1999. Lipopolysaccharide enhances FcgammaR-dependent functions in vivo through CD11b/CD18 up-regulation. Immunology, 97, 429–437.
- Willicombe M, Brookes P, Sergeant R, et al. 2012. De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy. Transplantation, 94, 172–177.
- Yoshizawa A, Egawa H, Yurugi K, et al. 2013. Significance of semiquantitative assessment of preformed donor-specific antibody using luminex single bead assay in living related liver transplantation. Clin Dev Immunol, 2013, 972705.